The Ovarian Cancer story has to change, Aspira is passionately dedicated to making a difference.

We are committed to solving women's health issues for all ethnicities, stages, and ages. Our data-driven approach delivers solutions that help women take control of their gynecologic health and empowers providers to deliver optimal care. We are using our 10+ years of experience in ovarian cancer risk assessment to develop a cutting-edge portfolio of pelvic mass products.

Relentless pursuit of products to improve ovarian cancer detection and care. Learn about why OVA1plus is the best way to assess risk prior to surgery.
Learn More
Hereditary Gynecologic cancer detection and carrier screening. Learn about your inherited risk through genetic testing.
Learn More
Aspira Synergy is a technology transfer platform that enables our customers to bring in-house the ability to perform specialty testing. Learn more about how to bring both OVA1plus and state-of-the-art genetic testing into your laboratory.
Learn More

OVA1 is great in that it can help to avoid second procedures on patients and second operations which can be associated with higher morbidity.
- Jonathan Black MD, MPH
OVA1^®plus has added to our armamentarium as physicians by decreasing the false positive rate up to 50%
- Howard C. Mandel MD, FACOG

We are always looking for talented, driven individuals to join our team of innovators. We are a small company with some very big ideas.

Are you ready to help us inspire change in women's health? Then we want to hear from you!

Join Us!